KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Non Operating Income: 2016-2024

Historic Non Operating Income for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to -$87.0 million.

  • Moderna's Non Operating Income rose 129.63% to $8.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$37.0 million, marking a year-over-year increase of 72.79%. This contributed to the annual value of -$87.0 million for FY2024, which is 29.84% up from last year.
  • Moderna's Non Operating Income amounted to -$87.0 million in FY2024, which was up 29.84% from -$124.0 million recorded in FY2023.
  • In the past 5 years, Moderna's Non Operating Income ranged from a high of -$6.0 million in FY2020 and a low of -$124.0 million during FY2023.
  • Over the past 3 years, Moderna's median Non Operating Income value was -$87.0 million (recorded in 2024), while the average stood at -$85.3 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 383.33% in 2021, then rose by 29.84% in 2024.
  • Over the past 5 years, Moderna's Non Operating Income (Yearly) stood at -$6.0 million in 2020, then tumbled by 383.33% to -$29.0 million in 2021, then crashed by 55.17% to -$45.0 million in 2022, then crashed by 175.56% to -$124.0 million in 2023, then increased by 29.84% to -$87.0 million in 2024.